Professional Records
License Records
Diane Macdougall
License #:
2107993 - Expired
Expiration Date:
Jan 5, 1984
Type:
Cosmetologist Type 2
Diane Macdougall Phones & Addresses
-
21715 California St, St Clr Shores, MI 48080
-
Saint Clair Shores, MI
-
54512 Burlington Dr, Utica, MI 48315 (586) 677-6265 (586) 677-7351 (586) 697-6229
-
Shelby Township, MI
-
4878 Ashley Ct, Waterford, MI 48329 (248) 673-3534 (810) 547-8208
-
Redford, MI
-
2500 Brockton Ave, Royal Oak, MI 48067 (248) 547-8208
-
Sterling Heights, MI
-
Southfield, MI
-
Macomb, MI
Publications
Us Patents
Selective Manipulation Of Triglyceride, Hdl And Ldl Parameters With 6-(5-Carboxy-5-Methyl-Hexyloxy)-2,2-Dimethylhexanoic Acid Monocalcium Salt
View pageUS Patent:
20040229954, Nov 18, 2004
Filed:
May 13, 2004
Appl. No.:
10/844879
Inventors:
Diane MacDougall - Ann Arbor MI, US
Rebecca Bakker-Arkema - Ann Arbor MI, US
Rebecca Bakker-Arkema - Ann Arbor MI, US
International Classification:
A61K031/19
US Classification:
514/574000
Abstract:
Methods for selectively modulating triglyceride, high-density lipoprotein, and low-density lipoprotein levels in a patient by administering a certain dose of 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt are disclosed.
Method Of Lowering Crp And Reducing Systemic Inflammation
View pageUS Patent:
20040167229, Aug 26, 2004
Filed:
Nov 13, 2003
Appl. No.:
10/712859
Inventors:
Rebecca Bakker-Arkema - Ann Arbor MI, US
Ok Hwang - Ann Arbor MI, US
Sotirios Karathanasis - Carmel IN, US
Diane MacDougall - Ann Arbor MI, US
Ok Hwang - Ann Arbor MI, US
Sotirios Karathanasis - Carmel IN, US
Diane MacDougall - Ann Arbor MI, US
International Classification:
A61K031/12
A61K031/10
A01N031/14
A61K031/10
A01N031/14
US Classification:
514/675000, 514/712000, 514/722000
Abstract:
Disclosed are methods of lowering plasma CRP levels, reducing systemic inflammation, and inhibiting proinflammatory cytokine induced CRP production by administering an effective amount of a substituted dialkyl ether, substituted alkyl, substituted aryl-alkyl, substituted dialkyl thioether, substituted dialkyl ketone, substituted-alkyl, or a pharmaceutically acceptable salt of the substituted dialkyl ether, substituted alkyl, substituted aryl-alkyl, substituted dialkyl thioether, substituted dialkyl ketone, or substituted-alkyl or a pharmaceutical composition comprising a substituted dialkyl ether, substituted alkyl, substituted aryl-alkyl, substituted dialkyl thioether, substituted dialkyl ketone, substituted-alkyl.
Triplet Combination Formulations And Methods For Treating Or Reducing The Risk Of Cardiovascular Disease
View pageUS Patent:
20210361618, Nov 25, 2021
Filed:
Feb 8, 2018
Appl. No.:
16/484704
Inventors:
- Ann Arbor MI, US
Diane MacDougall - Ann Arbor MI, US
Diane MacDougall - Ann Arbor MI, US
International Classification:
A61K 31/397
A61K 31/194
A61K 31/405
A61K 31/366
A61K 31/505
A61K 31/47
A61P 3/06
A61P 9/10
A61K 31/194
A61K 31/405
A61K 31/366
A61K 31/505
A61K 31/47
A61P 3/06
A61P 9/10
Abstract:
Disclosed herein are compositions comprising ETC-1002; Ezetimibe; a statin; and one or more pharmaceutical excipients or carriers. Also disclosed herein are methods for using said composition. Uses include methods of treating cardiovascular disease or reducing the risk of cardiovascular disease in a subject. Uses also include methods of treating hypercholesterolemia and/or dyslipidemias in a subject.